Healthcare Aug 01, 2022 03:11 PM (GMT+8) · EqualOcean
In June 2022, Acumen Biomedical(Chinese:亚通生物) closed its Series A financing round worth nearly 100 million of CNY led by Apricot Capital(Chinese: 杏泽资本) with participation from Guolian Xinchuang(Chinese:无锡国联新创), BR Capital(Chinese:博润资本), Hoshi Capital(Chinese:红什资本). The proceeds will be used to further automate the company’s product lines and expand new product pipelines. Founded in 2020, the startup is a producer of biomedical consumables, providing customers with comprehensive solutions and customized services for related consumables. Acumen entered the supplier system of some public-traded IVD companies thanks to its team’s experience and resources in product development, production management, etc.